ArticleEJHaem2024

Unlocking the potential of synthetic patients for accelerating clinical trials: Results of the first GIMEMA experience on acute myeloid leukemia patients.

Alfonso Piciocchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.